年轻女性相关暴发性心肌炎与细小病毒 B19 有关。

Fulminant myocarditis parvovirus B19 related in a young woman.

机构信息

Cardiosurgery Unit, Department of Cardiac-Thorac-Vascular Sciences and Public Health, Via Giustiniani 2, 36100, Padua, Italy.

Cardiovascular Pathology Unit, Department of Cardiac-Thorac-Vascular Sciences and Public Health, Padua, Italy.

出版信息

J Artif Organs. 2021 Dec;24(4):498-502. doi: 10.1007/s10047-021-01247-7. Epub 2021 Jan 24.

DOI:10.1007/s10047-021-01247-7

PMID:33486632

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8571226/

Abstract

We present the case of a 18-year-old female with fulminant lymphocytic myocarditis caused by Parvovirus B19 (PVB19), successfully treated using temporary LVAD. In the literature there is no consensus on the surgical strategy. While some surgeons prefer to use a single device supporting only the LV, others prefer to start immediately with a biventricular supporting. At pre-procedural ultrasound evaluation, her anatomical features were not suitable for a percutaneous device such as the Impella. Thus, a temporary paracorporeal continuous flow LVAD was inserted. The heart recovery allowed LVAD removal 9 days after the implant.

摘要

我们报告了一例由细小病毒 B19（PVB19）引起的暴发性淋巴细胞性心肌炎的 18 岁女性患者，成功地使用临时左心室辅助装置（LVAD）进行了治疗。在文献中，对于手术策略尚无共识。一些外科医生倾向于使用仅支持左心室的单个装置，而另一些外科医生则倾向于立即开始使用双心室支持。在术前超声评估中，她的解剖结构不适合使用经皮装置，如 Impella。因此，插入了临时体外连续流左心室辅助装置。心脏恢复后，在植入后 9 天移除了 LVAD。